Blood Cancers

Treatment with the Latest Lymphoma Medications

In the past several years, people with non-Hodgkin lymphoma have benefited from the development of many new drugs for this disease — especially therapies that target the unique biological features of lymphoma and zero in on the specific molecules involved in cancer growth. Your doctors at NewYork-Presbyterian have access to the latest novel treatments and choose those best suited for you and your particular type of lymphoma. They are also devising new, more effective therapies to further extend survival.

Special Expertise and Leadership in T-Cell Lymphomas

Conventional chemotherapy regimens are markedly inadequate for T-cell lymphomas. To overcome a challenging prognosis, our lymphoma specialists are leveraging developments in biology and experimental therapies to create novel initial chemotherapy-free treatments, with the goal of improving patients' outcomes very early in the game. They also forged the first Global T-Cell Lymphoma Consortium, which brings together investigators from major T-cell lymphoma centers in Asia, North America, and Europe. Member sites will synchronize their research, accruing patients for innovative clinical trials. This consortium is designed to hasten the development of better treatments for peripheral T-cell lymphoma (PTCL).

Precise Radiation Therapy

If your treatment plan includes radiation, you can receive highly precise radiation therapy in one of our modern radiation oncology units.

• We use the latest finely targeted radiation treatment methods, including image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT). These techniques guide radiation beams to match the exact shape of your tumor and allow for dose adjustments.
• Using IGRT and IMRT, we can kill more cancer cells while damaging fewer healthy cells — which could mean fewer side effects for you.

Exceptional Experience in Stem Cell Transplantation

We perform more than 200 stem cell transplants a year. If your doctor recommends a transplant, you'll receive it from a team with an established track record in a hospital where all your medical needs can be addressed.

• We have advanced transplant units offering individual monitoring and special airflow systems for patients with weakened immune systems.
• We also have special expertise in transplants from mismatched donors and offer approaches that reduce the risk of transplant-related complications.

Clinical Trials

As leaders in the field of lymphoma, we offer the largest portfolio of clinical trials in the world for people with this disease. 

• Members of our team of lymphoma experts have invented new drugs for lymphomas and led their clinical development. They have also directed international studies leading to the approval of these therapies in other countries.
• Through clinical trials, our doctors aim to bring the latest advances in the understanding and treatment of lymphoma from the laboratory to our patients. You may have the opportunity to participate in a clinical trial assessing a promising new therapy.

Click here to Learn More.

Specialists and Subspecialists in Every Area

At NewYork-Presbyterian, we treat the whole person. Through our matrix cancer centers, you'll have access to the full resources of our top-ranked academic medical centers, including specialists from all areas who collaborate with our cancer experts to provide comprehensive care. This collaboration makes NewYork-Presbyterian an excellent choice for people with non-Hodgkin lymphoma.